These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 392480)

  • 21. The treatment of inveterate vulvo-vaginal candidosis.
    Bingham JS
    Acta Derm Venereol Suppl (Stockh); 1986; 121():125-9. PubMed ID: 3459339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of miconazole on the ultrastructure of Candida albicans.
    De Nollin S; Borgers M; Van Belle H
    Proc R Soc Med; 1977; 70 Suppl 4(Suppl 4):19-23. PubMed ID: 122689
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of vaginal ointment of honey and clotrimazole for treatment of vulvovaginal candidiasis: A random clinical trial.
    Banaeian S; Sereshti M; Rafieian M; Farahbod F; Kheiri S
    J Mycol Med; 2017 Dec; 27(4):494-500. PubMed ID: 28760590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antifungal imidazoles: clotrimazole and miconazole.
    Milne LJ
    Scott Med J; 1978 Apr; 23(2):149-52. PubMed ID: 644298
    [No Abstract]   [Full Text] [Related]  

  • 25. Miconazole for the treatment of vulvovaginal candidiasis.
    Regidor PA; Thamkhantho M; Chayachinda C; Palacios S
    J Obstet Gynaecol; 2023 Dec; 43(1):2195001. PubMed ID: 37029724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antifungal activity of clotrimazole against Candida albicans depends on carbon sources, growth phase and morphology.
    Kasper L; Miramón P; Jablonowski N; Wisgott S; Wilson D; Brunke S; Hube B
    J Med Microbiol; 2015 Jul; 64(7):714-723. PubMed ID: 25976001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents.
    Choukri F; Benderdouche M; Sednaoui P
    J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
    Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
    Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotyping and Persistence of Candida albicans from Pregnant Women with Vulvovaginal Candidiasis.
    Tapia CV; Hermosilla G; Fortes P; Alburquenque C; Bucarey S; Salinas H; Rodas PI; Díaz MC; Magne F
    Mycopathologia; 2017 Apr; 182(3-4):339-347. PubMed ID: 27882525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful treatment of experimental murine vulvovaginal candidiasis with gentian violet.
    Bonfim AP; Sakita KM; Faria DR; Arita GS; Rodrigues-Vendramini FA; Capoci IR; Braga AG; Mosca VA; Junior AG; Kioshima ÉS; Bonfim-Mendonça PS; Svidzinski TI
    Future Microbiol; 2023 Nov; 18():1137-1146. PubMed ID: 37830930
    [No Abstract]   [Full Text] [Related]  

  • 31. Acute vaginal candidosis model in the immunocompromized rat to evaluate delivery systems for antimycotics.
    Foldvari M; Radhi J; Yang G; He Z; Rennie R; Wearley L
    Mycoses; 2000; 43(11-12):393-401. PubMed ID: 11204356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaginal antimycotics and the risk for spontaneous abortions.
    Daniel S; Rotem R; Koren G; Lunenfeld E; Levy A
    Am J Obstet Gynecol; 2018 Jun; 218(6):601.e1-601.e7. PubMed ID: 29510088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Six-day clotrimazole therapy in vaginal candidosis.
    Masterton G; Henderson J; Napier IR; Moffet M
    Curr Med Res Opin; 1975; 3(2):83-8. PubMed ID: 1095310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surface-modified mucoadhesive microgels as a controlled release system for miconazole nitrate to improve localized treatment of vulvovaginal candidiasis.
    Kenechukwu FC; Attama AA; Ibezim EC; Nnamani PO; Umeyor CE; Uronnachi EM; Gugu TH; Momoh MA; Ofokansi KC; Akpa PA
    Eur J Pharm Sci; 2018 Jan; 111():358-375. PubMed ID: 28986195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antifungal susceptibilities of Candida species isolated from the patients with vaginal candidiasis.
    Nagashima M; Yamagishi Y; Mikamo H
    J Infect Chemother; 2016 Feb; 22(2):124-6. PubMed ID: 26627336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrence of vulvovaginal candidosis during pregnancy. Comparison of miconazole vs nystatin treatment.
    Wallenburg HC; Wladimiroff JW
    Obstet Gynecol; 1976 Oct; 48(4):491-4. PubMed ID: 787858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drugs for treatment of vulvovaginal candidiasis: comparative efficacy of agents and regimens.
    Doering PL; Santiago TM
    DICP; 1990 Nov; 24(11):1078-83. PubMed ID: 2275233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and antifungal susceptibility of Candida albicans and its related species Candida dubliniensis and Candida africana isolated from vulvovaginal samples in a hospital of Argentina.
    Theill L; Dudiuk C; Morano S; Gamarra S; Nardin ME; Méndez E; Garcia-Effron G
    Rev Argent Microbiol; 2016; 48(1):43-9. PubMed ID: 26922471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antifungal activities of two new azasordarins, GW471552 and GW471558, in experimental models of oral and vulvovaginal candidiasis in immunosuppressed rats.
    Martinez A; Ferrer S; Santos I; Jimenez E; Sparrowe J; Regadera J; De Las Heras FG; Gargallo-Viola D
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3304-9. PubMed ID: 11709301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaginal nystatin versus oral fluconazole for the treatment for recurrent vulvovaginal candidiasis.
    Fan S; Liu X; Wu C; Xu L; Li J
    Mycopathologia; 2015 Feb; 179(1-2):95-101. PubMed ID: 25416649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.